Physician profile
Waymon E Lewis
NPI 1558397612
$7,170.95
in general payments reported to CMS, 2019-2025
26 companies · $324 in 2025
The $324 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,791 · 2020: $72.50 · 2021: $2,520 · 2022: $302 · 2023: $189 · 2024: $973 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $800 · Food and Beverage: $636 · Travel and Lodging: $49.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $800.00 |
| Food and Beverage | $636.31 |
| Travel and Lodging | $49.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $4,142.19 | 2019-2024 | |
| Gramercy Extremity Orthopedics LLC | $829.19 | 2023-2024 | |
| Arthrosurface Incorporated | $560.26 | 2019 | |
| Orthofix Medical, INC. | $274.10 | 2019-2025 | Truelok Evo, Truelok, Physio-Stim |
| Smith+Nephew, INC. | $211.18 | 2019-2025 | Collagenase Santyl, Grafix Pl |
| Treace Medical Concepts, INC. | $159.81 | 2019 | |
| Melinta Therapeutics, LLC | $149.11 | 2019-2022 | |
| Convatec INC. | $115.91 | 2021-2025 | |
| Nevro Corp. | $102.26 | 2022-2024 | Senza |
| Horizon Therapeutics Plc | $82.59 | 2020-2023 | Krystexxa |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $81.97 | 2019-2023 | Jublia |
| Cardiovascular Systems INC. | $77.62 | 2022 | |
| Paratek Pharmaceuticals, INC. | $73.52 | 2022-2025 | Nuzyra |
| Amgen INC. | $52.97 | 2024 | Krystexxa |
| Kerecis Limited | $35.03 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $31.79 | 2021 | |
| Tactile Systems Technology INC | $28.50 | 2019-2020 | |
| Crossroads Extremity Systems, LLC | $25.29 | 2020 | |
| Abbvie INC. | $24.30 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $22.17 | 2019 | |
| Globus Medical, INC. | $20.61 | 2025 | Senza |
| Merck Sharp & Dohme LLC | $17.05 | 2019 | |
| Depuy Synthes Sales INC. | $16.73 | 2025 | |
| Acell, INC. | $13.29 | 2019 | |
| Cpm Medical Consultants, LLC | $11.88 | 2020 | |
| Nabriva Therapeutics, Plc | $11.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Waymon Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.